|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 59.66 USD | +0.29% |
|
-10.97% | +102.31% |
| 07-20 | Goldman Sachs Adjusts Moderna Price Target to $67 From $49, Maintains Neutral Rating | MT |
| 07-16 | Moderna advances its cancer therapy assessment, but the stock slides |
Insider Transaction History
Latest insider transactions for Moderna, Inc.
| Date | Insider | Type | Main position | Quantity | Price | Amount | % Market Cap. | |
|---|---|---|---|---|---|---|---|---|
| 15/07/26 | Fiscal year | Chairperson | 160,008 | 43.38 | 4.63M | 0.0403% | ||
| 08/07/26 | Free | Director | 14,766 | 67.01 | 989K | 0.0037% | ||
| 05/07/26 | Free | Executive/Senior Manager | 57,022 | 73.80 | 4.21M | 0.0144% | ||
| 02/07/26 | Fiscal year | Chief Financial Officer | 3,607 | 23.65 | 50.97K | 0.0009% | ||
| 15/06/26 | Fiscal year | Chairperson | 160,008 | 35.26 | 3.76M | 0.0403% | ||
| 05/06/26 | Fiscal year | Chief Financial Officer | 29,301 | 16.82 | 294K | 0.0074% | ||
| 05/06/26 | Fiscal year | General Counsel | 29,301 | 16.82 | 294K | 0.0074% | ||
| 01/06/26 | Fiscal year | Chairperson | 23,052 | 15.38 | 212K | 0.0058% | ||
| 01/06/26 | Fiscal year | Chief Financial Officer | 6,147 | 15.38 | 56.49K | 0.0015% | ||
| 01/06/26 | Fiscal year | General Counsel | 5,377 | 15.38 | 49.41K | 0.0014% | ||
| 28/05/26 | Fiscal year | General Counsel | 815 | 15.54 | 7.57K | 0.0002% | ||
| 28/05/26 | Fiscal year | Chairperson | 1,515 | 15.52 | 14.04K | 0.0004% | ||
| 28/05/26 | Fiscal year | Chief Financial Officer | 815 | 15.54 | 7.57K | 0.0002% | ||
| 21/05/26 | Other | Founder | 0 | 46.88 | - | 0% | ||
| 21/05/26 | Flagship Pioneering, LLC
| Fiscal year | Company | 27,789 | 33.00 | 611K | 0.0070% | |
| 15/05/26 | Fiscal year | Chairperson | 160,008 | 33.78 | 3.6M | 0.0403% | ||
| 06/05/26 | Free | Director | 11,773 | 53.27 | 627K | 0.0030% | ||
| 06/05/26 | Free | Director | 8,371 | 53.27 | 446K | 0.0021% | ||
| 06/05/26 | Free | Director | 10,639 | 53.27 | 567K | 0.0027% | ||
| 06/05/26 | Free | Director | 8,371 | 53.27 | 446K | 0.0021% | ||
| 06/05/26 | Free | Director | 11,773 | 53.27 | 627K | 0.0030% | ||
| 06/05/26 | Free | Founder | 12,908 | 53.27 | 688K | 0.0033% | ||
| 06/05/26 | Free | Director | 8,371 | 53.27 | 446K | 0.0021% | ||
| 01/05/26 | Sell | Director | -5,682 | 46.63 | - | 0.0014% | ||
| 02/04/26 | Fiscal year | Chief Financial Officer | 3,609 | 16.31 | 35.17K | 0.0009% | ||
| 05/03/26 | Fiscal year | Chief Financial Officer | 29,298 | 18.84 | 330K | 0.0074% | ||
| 05/03/26 | Fiscal year | General Counsel | 29,298 | 18.84 | 330K | 0.0074% | ||
| 01/03/26 | Other | Chief Executive Officer | 250,932 | - | - | 0.0635% | ||
| 27/02/26 | Fiscal year | Chairperson | 389,616 | 16.85 | 996K | 0.0997% | ||
| 27/02/26 | Fiscal year | General Counsel | 134,318 | 33.00 | 1.41M | 0.0344% | ||
| 27/02/26 | Fiscal year | Chief Financial Officer | 114,539 | 16.86 | 275K | 0.0293% | ||
| 23/02/26 | Fiscal year | Chairperson | 480,027 | 34.00 | 10.88M | 0.1229% | ||
| 11/02/26 | Free | Chief Financial Officer | 3,908 | 13.73 | 53.66K | 0.0010% | ||
| 11/02/26 | Free | General Counsel | 3,964 | 14.13 | 56.01K | 0.0010% | ||
| 11/02/26 | Free | Chief Executive Officer | 16,721 | 13.69 | 229K | 0.0043% | ||
| 11/02/26 | Free | Chairperson | 7,246 | 13.69 | 99.18K | 0.0019% | ||
| 05/01/26 | Fiscal year | Chief Financial Officer | 3,684 | 10.78 | 24.07K | 0.0009% | ||
| 11/12/25 | Other | Founder | 0 | - | - | 0% | ||
| 11/12/25 | Flagship Pioneering, LLC
| Fiscal year | Company | 71,559 | 20.19 | 963K | 0.0183% | |
| 11/12/25 | Fiscal year | Chief Executive Officer | 1,376,146 | 10.90 | 7.5M | 0.3522% | ||
| 09/12/25 | Sell | Director | 504 | 27.60 | 13.91K | 0.0001% | ||
| 05/12/25 | Fiscal year | Chief Financial Officer | 117,197 | 8.31 | 582K | 0.0300% | ||
| 05/12/25 | Fiscal year | General Counsel | 117,197 | 8.31 | 582K | 0.0300% | ||
| 01/12/25 | Fiscal year | General Counsel | 579 | 8.48 | 2.94K | 0.0001% | ||
| 01/12/25 | Fiscal year | Chairperson | 1,620 | 8.48 | 8.21K | 0.0004% | ||
| 26/11/25 | Fiscal year | Chairperson | 5,084 | 8.09 | 24.58K | 0.0013% | ||
| 26/11/25 | Fiscal year | Chief Financial Officer | 2,738 | 8.10 | 13.26K | 0.0007% | ||
| 26/11/25 | Fiscal year | General Counsel | 2,738 | 8.10 | 13.26K | 0.0007% | ||
| 03/10/25 | Fiscal year | Chief Financial Officer | 3,609 | 9.25 | 19.94K | 0.0009% | ||
| 02/10/25 | Fiscal year | Director | 2,878 | - | - | 0.0007% | ||
- Stock Market
- Stocks
- MRNA Stock
- Company Moderna, Inc.
- Insider transactions
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















